Loading…

A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine

A method was developed for the separation and quantification of the anti-nerve agent pyridostgmine bromide (PB;3-dimethylaminocarbonyloxy- N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1 H-purine-2,6-...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2001-12, Vol.26 (5), p.939-947
Main Authors: Abu-Qare, Aqel W, Abou-Donia, Mohamed B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303
cites cdi_FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303
container_end_page 947
container_issue 5
container_start_page 939
container_title Journal of pharmaceutical and biomedical analysis
container_volume 26
creator Abu-Qare, Aqel W
Abou-Donia, Mohamed B
description A method was developed for the separation and quantification of the anti-nerve agent pyridostgmine bromide (PB;3-dimethylaminocarbonyloxy- N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1 H-purine-2,6-dione) in rat plasma and urine. The compounds were extracted using C 18 Sep-Pak R cartridges then analyzed by high performance liquid chromatography (HPLC) with reversed phase C 18 column, and UV detection at 280 nm. The compounds were separated using gradient of 1–85% acetonitrile in water (pH 3.0) at a flow rate ranging between 1 and 1.5 ml/min in a period of 14 min. The retention times ranged from 8.8 to 11.5 min. The limits of detection were ranged between 100 and 200 ng/ml, while limits of quantitation were 150–200 ng/ml. Average percentage recovery of five spiked plasma samples were 70.9±9.5, 73.7±9.8, 88.6±9.3, 83.9±7.8, and from urine 69.1±8.5, 74.5±8.7, 85.9±9.8, 83.2±9.3, for pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine, respectively. The relationship between peak areas and concentration was linear over range between 100 and 1000 ng/ml. The resulting chromatograms showed no interfering peaks from endogenous plasma or urine components. This method was applied to analyze these compounds following oral administration in rats.
doi_str_mv 10.1016/S0731-7085(01)00448-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72200874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708501004484</els_id><sourcerecordid>18233704</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhYMo7rj6CEpuFAVbK530T65kGdQVBhRU8C5UJ9VOpLszm2QW5jF8Y7tnBvdyL0Kok-9UJTmMPRfwToCo33-HRoqigbZ6DeINgFJtoR6wlWgbWZS1-vWQrf4jF-xJSn8AoBJaPWYXQtQAEuoV-3vFb3HwDjM5fv1ts-Yj5W1wvA-R5y1xR5ni6CfMPkw89Hx3iN6FlP3vWSXexTB6R285Wso4S2G3pelUHoY097aHec21dxwnxy32PS1OP_GIme8GTCMej_Zx1p-yRz0OiZ6d90v289PHH-vrYvP185f11aawqm1zoXSpy06WWkuqO3CdUrLvXG0RKoWtrKtag0XRgO1QA2hsQZMsFZR1P79dXrJXp767GG72lLIZfbI0DDhR2CfTlCVA26h7QdGWUjawgNUJtDGkFKk3u-hHjAcjwCyhmWNoZknEgDDH0Mzie3EesO9Gcneuc0oz8PIMYLI49BEn69Mdp6CpGi1m7sOJo_nfbj1Fk6ynyZLzkWw2Lvh7rvIPpFi0FQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18233704</pqid></control><display><type>article</type><title>A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine</title><source>ScienceDirect Freedom Collection</source><creator>Abu-Qare, Aqel W ; Abou-Donia, Mohamed B</creator><creatorcontrib>Abu-Qare, Aqel W ; Abou-Donia, Mohamed B</creatorcontrib><description>A method was developed for the separation and quantification of the anti-nerve agent pyridostgmine bromide (PB;3-dimethylaminocarbonyloxy- N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1 H-purine-2,6-dione) in rat plasma and urine. The compounds were extracted using C 18 Sep-Pak R cartridges then analyzed by high performance liquid chromatography (HPLC) with reversed phase C 18 column, and UV detection at 280 nm. The compounds were separated using gradient of 1–85% acetonitrile in water (pH 3.0) at a flow rate ranging between 1 and 1.5 ml/min in a period of 14 min. The retention times ranged from 8.8 to 11.5 min. The limits of detection were ranged between 100 and 200 ng/ml, while limits of quantitation were 150–200 ng/ml. Average percentage recovery of five spiked plasma samples were 70.9±9.5, 73.7±9.8, 88.6±9.3, 83.9±7.8, and from urine 69.1±8.5, 74.5±8.7, 85.9±9.8, 83.2±9.3, for pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine, respectively. The relationship between peak areas and concentration was linear over range between 100 and 1000 ng/ml. The resulting chromatograms showed no interfering peaks from endogenous plasma or urine components. This method was applied to analyze these compounds following oral administration in rats.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/S0731-7085(01)00448-4</identifier><identifier>PMID: 11600306</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Acetaminophen ; Acetaminophen - analysis ; Acetaminophen - blood ; Acetaminophen - urine ; Acetylsalicylic acid ; Analysis ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - analysis ; Anti-Inflammatory Agents, Non-Steroidal - blood ; Anti-Inflammatory Agents, Non-Steroidal - urine ; Aspirin - analysis ; Aspirin - blood ; Aspirin - urine ; Biological and medical sciences ; Caffeine ; Caffeine - analysis ; Caffeine - blood ; Caffeine - urine ; Calibration ; Central Nervous System Stimulants - analysis ; Central Nervous System Stimulants - blood ; Central Nervous System Stimulants - urine ; Chromatography, High Pressure Liquid ; General pharmacology ; Medical sciences ; Pharmacology. Drug treatments ; Pyridostigmine bromide ; Pyridostigmine Bromide - analysis ; Pyridostigmine Bromide - blood ; Pyridostigmine Bromide - urine ; Rats ; Rats, Sprague-Dawley ; Reproducibility of Results</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2001-12, Vol.26 (5), p.939-947</ispartof><rights>2001 Elsevier Science B.V.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303</citedby><cites>FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14075791$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11600306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abu-Qare, Aqel W</creatorcontrib><creatorcontrib>Abou-Donia, Mohamed B</creatorcontrib><title>A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>A method was developed for the separation and quantification of the anti-nerve agent pyridostgmine bromide (PB;3-dimethylaminocarbonyloxy- N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1 H-purine-2,6-dione) in rat plasma and urine. The compounds were extracted using C 18 Sep-Pak R cartridges then analyzed by high performance liquid chromatography (HPLC) with reversed phase C 18 column, and UV detection at 280 nm. The compounds were separated using gradient of 1–85% acetonitrile in water (pH 3.0) at a flow rate ranging between 1 and 1.5 ml/min in a period of 14 min. The retention times ranged from 8.8 to 11.5 min. The limits of detection were ranged between 100 and 200 ng/ml, while limits of quantitation were 150–200 ng/ml. Average percentage recovery of five spiked plasma samples were 70.9±9.5, 73.7±9.8, 88.6±9.3, 83.9±7.8, and from urine 69.1±8.5, 74.5±8.7, 85.9±9.8, 83.2±9.3, for pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine, respectively. The relationship between peak areas and concentration was linear over range between 100 and 1000 ng/ml. The resulting chromatograms showed no interfering peaks from endogenous plasma or urine components. This method was applied to analyze these compounds following oral administration in rats.</description><subject>Acetaminophen</subject><subject>Acetaminophen - analysis</subject><subject>Acetaminophen - blood</subject><subject>Acetaminophen - urine</subject><subject>Acetylsalicylic acid</subject><subject>Analysis</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - analysis</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - blood</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - urine</subject><subject>Aspirin - analysis</subject><subject>Aspirin - blood</subject><subject>Aspirin - urine</subject><subject>Biological and medical sciences</subject><subject>Caffeine</subject><subject>Caffeine - analysis</subject><subject>Caffeine - blood</subject><subject>Caffeine - urine</subject><subject>Calibration</subject><subject>Central Nervous System Stimulants - analysis</subject><subject>Central Nervous System Stimulants - blood</subject><subject>Central Nervous System Stimulants - urine</subject><subject>Chromatography, High Pressure Liquid</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyridostigmine bromide</subject><subject>Pyridostigmine Bromide - analysis</subject><subject>Pyridostigmine Bromide - blood</subject><subject>Pyridostigmine Bromide - urine</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reproducibility of Results</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkd2KFDEQhYMo7rj6CEpuFAVbK530T65kGdQVBhRU8C5UJ9VOpLszm2QW5jF8Y7tnBvdyL0Kok-9UJTmMPRfwToCo33-HRoqigbZ6DeINgFJtoR6wlWgbWZS1-vWQrf4jF-xJSn8AoBJaPWYXQtQAEuoV-3vFb3HwDjM5fv1ts-Yj5W1wvA-R5y1xR5ni6CfMPkw89Hx3iN6FlP3vWSXexTB6R285Wso4S2G3pelUHoY097aHec21dxwnxy32PS1OP_GIme8GTCMej_Zx1p-yRz0OiZ6d90v289PHH-vrYvP185f11aawqm1zoXSpy06WWkuqO3CdUrLvXG0RKoWtrKtag0XRgO1QA2hsQZMsFZR1P79dXrJXp767GG72lLIZfbI0DDhR2CfTlCVA26h7QdGWUjawgNUJtDGkFKk3u-hHjAcjwCyhmWNoZknEgDDH0Mzie3EesO9Gcneuc0oz8PIMYLI49BEn69Mdp6CpGi1m7sOJo_nfbj1Fk6ynyZLzkWw2Lvh7rvIPpFi0FQ</recordid><startdate>20011201</startdate><enddate>20011201</enddate><creator>Abu-Qare, Aqel W</creator><creator>Abou-Donia, Mohamed B</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20011201</creationdate><title>A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine</title><author>Abu-Qare, Aqel W ; Abou-Donia, Mohamed B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acetaminophen</topic><topic>Acetaminophen - analysis</topic><topic>Acetaminophen - blood</topic><topic>Acetaminophen - urine</topic><topic>Acetylsalicylic acid</topic><topic>Analysis</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - analysis</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - blood</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - urine</topic><topic>Aspirin - analysis</topic><topic>Aspirin - blood</topic><topic>Aspirin - urine</topic><topic>Biological and medical sciences</topic><topic>Caffeine</topic><topic>Caffeine - analysis</topic><topic>Caffeine - blood</topic><topic>Caffeine - urine</topic><topic>Calibration</topic><topic>Central Nervous System Stimulants - analysis</topic><topic>Central Nervous System Stimulants - blood</topic><topic>Central Nervous System Stimulants - urine</topic><topic>Chromatography, High Pressure Liquid</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyridostigmine bromide</topic><topic>Pyridostigmine Bromide - analysis</topic><topic>Pyridostigmine Bromide - blood</topic><topic>Pyridostigmine Bromide - urine</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abu-Qare, Aqel W</creatorcontrib><creatorcontrib>Abou-Donia, Mohamed B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abu-Qare, Aqel W</au><au>Abou-Donia, Mohamed B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2001-12-01</date><risdate>2001</risdate><volume>26</volume><issue>5</issue><spage>939</spage><epage>947</epage><pages>939-947</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>A method was developed for the separation and quantification of the anti-nerve agent pyridostgmine bromide (PB;3-dimethylaminocarbonyloxy- N-methyl pyridinium bromide), the analgesic drugs acetaminophen and acetylsalicylic acid, and the stimulant caffeine (3,7-dihydro-1,3,7-trimethyl-1 H-purine-2,6-dione) in rat plasma and urine. The compounds were extracted using C 18 Sep-Pak R cartridges then analyzed by high performance liquid chromatography (HPLC) with reversed phase C 18 column, and UV detection at 280 nm. The compounds were separated using gradient of 1–85% acetonitrile in water (pH 3.0) at a flow rate ranging between 1 and 1.5 ml/min in a period of 14 min. The retention times ranged from 8.8 to 11.5 min. The limits of detection were ranged between 100 and 200 ng/ml, while limits of quantitation were 150–200 ng/ml. Average percentage recovery of five spiked plasma samples were 70.9±9.5, 73.7±9.8, 88.6±9.3, 83.9±7.8, and from urine 69.1±8.5, 74.5±8.7, 85.9±9.8, 83.2±9.3, for pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine, respectively. The relationship between peak areas and concentration was linear over range between 100 and 1000 ng/ml. The resulting chromatograms showed no interfering peaks from endogenous plasma or urine components. This method was applied to analyze these compounds following oral administration in rats.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>11600306</pmid><doi>10.1016/S0731-7085(01)00448-4</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2001-12, Vol.26 (5), p.939-947
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_72200874
source ScienceDirect Freedom Collection
subjects Acetaminophen
Acetaminophen - analysis
Acetaminophen - blood
Acetaminophen - urine
Acetylsalicylic acid
Analysis
Animals
Anti-Inflammatory Agents, Non-Steroidal - analysis
Anti-Inflammatory Agents, Non-Steroidal - blood
Anti-Inflammatory Agents, Non-Steroidal - urine
Aspirin - analysis
Aspirin - blood
Aspirin - urine
Biological and medical sciences
Caffeine
Caffeine - analysis
Caffeine - blood
Caffeine - urine
Calibration
Central Nervous System Stimulants - analysis
Central Nervous System Stimulants - blood
Central Nervous System Stimulants - urine
Chromatography, High Pressure Liquid
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Pyridostigmine bromide
Pyridostigmine Bromide - analysis
Pyridostigmine Bromide - blood
Pyridostigmine Bromide - urine
Rats
Rats, Sprague-Dawley
Reproducibility of Results
title A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A44%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20validated%20HPLC%20method%20for%20the%20determination%20of%20pyridostigmine%20bromide,%20acetaminophen,%20acetylsalicylic%20acid%20and%20caffeine%20in%20rat%20plasma%20and%20urine&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Abu-Qare,%20Aqel%20W&rft.date=2001-12-01&rft.volume=26&rft.issue=5&rft.spage=939&rft.epage=947&rft.pages=939-947&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/S0731-7085(01)00448-4&rft_dat=%3Cproquest_cross%3E18233704%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c488t-49292b32993e6b0db443fbd6ca054a8365690ca170cba9009a809e324026f0303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18233704&rft_id=info:pmid/11600306&rfr_iscdi=true